Suizhou Central Hospital
In research, Suizhou Central Hospital stands highest in Health Sciences (#3,593 of 11,982 worldwide), Medicine (#3,198 of 10,443 worldwide) and Life Sciences (#3,626 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 5.0× its share of world research.
- World rank, 2022–2025
- #7,313 of 28,054 · #16,479 all time
- Rank in China
- #1,473 of 3,058
- Research works
- 1.5k ▲ 19% vs 2013–17
- Citations
- 7.7k 5.1 per fractional work
- Top-10% rate
- 14.7% record average 16.5%
- Open access
- 51% world 28%
What is Suizhou Central Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #3,593 of 11,982 | 14.3% | 357 | #8193 | |
| MedicineField | #3,198 of 10,443 | 14.3% | 343 | #7065 | |
| Life SciencesDomain | #3,626 of 7,800 | 15.9% | 126 | #8202 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,224 of 3,579 | 13.3% | 85 | #7019 |
Each strip is that field’s whole ranked pool, with the notch where Suizhou Central Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#8,193 #3,593
- Medicine#7,065 #3,198
- Life Sciences#8,202 #3,626
- Biochemistry, Genetics and Molecular Biology#7,019 #3,224
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Suizhou Central Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 5.0× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 42.3 works5.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.3×. Every wedge is a field page.
- Immunology and Microbiology 3.3×
- Medicine 3.2×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Neuroscience 1.5×
- Nursing 1.4×
- Dentistry 1.1×
- Veterinary 0.7×
- Health Professions 0.5×
- Environmental Science 0.4×
- Engineering 0.3×
- Materials Science 0.3×
- Psychology 0.3×
- Chemistry 0.3×
- Agricultural and Biological Sciences 0.2×
- Chemical Engineering 0.2×
- Energy 0.2×
- Computer Science 0.1×
- Earth and Planetary Sciences 0.1×
- Mathematics 0.1×
- Decision Sciences 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Economics, Econometrics and Finance 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.1×
Which keywords describe research at Suizhou Central Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Epidemiology, Tumor Microenvironment, Oxidative Stress, Gene Expression, Cardiovascular Disease and Metastasis.
- RNA Regulation
- Cancer Progression
- Prognostic Markers
- Ferroptosis
- Survival Analysis
- Clinical Outcomes
- Ischemic Stroke
- Insulin Resistance
- Biogenesis
- Regulation
- Immunotherapy
- Clinical Practice Guidelines
- Global Burden
- Metastasis
- Metabolic Syndrome
- Risk Factors
- Management
- Cardiovascular Disease
- Oxidative Stress
- Epidemiology
- Inflammation
- Cancer
- Tumor Microenvironment
- Diagnosis
- Gene Expression
- Treatment
- Biomarkers
- Chemotherapy
- Immunity
- Cell Death
- Neuroprotection
- Complications
- Surgery
- Radiotherapy
- Epigenetic Regulation
- Neoadjuvant Therapy
- Lipid Peroxidation
- GPX4
- Revascularization
- Prevention Guidelines
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation58▲ 5.0×71 topics
- Epidemiology52▲ 2.4×95 topics
- Cancer46▲ 6.2×45 topics
- Oxidative Stress30▲ 3.3×48 topics
- Tumor Microenvironment24▲ 10.0×8 topics
- Cardiovascular Disease23▲ 3.8×30 topics
- Diagnosis20▲ 3.9×35 topics
- Management19▲ 4.4×25 topics
- Gene Expression19▲ 5.7×10 topics
- Risk Factors19▲ 3.1×27 topics
- Treatment18▲ 2.8×40 topics
- Metabolic Syndrome17▲ 3.9×20 topics
- Biomarkers16▲ 4.3×14 topics
- Metastasis16▲ 8.5×10 topics
- Chemotherapy16▲ 4.1×21 topics
- Global Burden16▲ 5.3×10 topics
- Immunity14▲ 6.2×9 topics
- Clinical Practice Guidelines13▲ 4.5×13 topics
- Cell Death13▲ 10×6 topics
- Immunotherapy13▲ 3.4×17 topics
- Neuroprotection13▲ 6.7×15 topics
- Regulation12▲ 4.0×10 topics
- Complications12▲ 4.3×16 topics
- Biogenesis11▲ 11×3 topics
- Surgery11▲ 5.6×9 topics
- Insulin Resistance11▲ 4.2×9 topics
- Radiotherapy10▲ 4.7×11 topics
- Ischemic Stroke10▲ 12×4 topics
- Epigenetic Regulation10▲ 8.2×4 topics
- Clinical Outcomes10▲ 8.0×4 topics
- Neoadjuvant Therapy9▲ 7.1×5 topics
- Survival Analysis9▲ 5.9×6 topics
- Lipid Peroxidation8▲ 15×2 topics
- Ferroptosis8▲ 20×1 topic
- GPX48▲ 20×1 topic
- Prognostic Markers8▲ 14×3 topics
- Revascularization8▲ 9.7×4 topics
- Cancer Progression8▲ 7.8×8 topics
- Prevention Guidelines8▲ 14×2 topics
- RNA Regulation8▲ 13×2 topics
Which research topics does Suizhou Central Hospital publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, Acute Ischemic Stroke Management and Inflammatory Biomarkers in Disease Prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 8 works
- 2 Cancer-related molecular mechanisms research Cancer Research 7 works
- 3 Acute Ischemic Stroke Management Epidemiology 7 works
- 4 Inflammatory Biomarkers in Disease Prognosis Oncology 6 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 6 RNA modifications and cancer Molecular Biology 5 works
- 7 MicroRNA in disease regulation Cancer Research 5 works
- 8 Circular RNAs in diseases Molecular Biology 5 works
- 9 Gut microbiota and health Molecular Biology 4 works
- 10 Esophageal and GI Pathology Surgery 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Suizhou Central Hospital's research output changed?
Output in 2018–2022 was 19% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.